Tactile Systems Technology, Inc., doing business as Tactile Medical, is a medical technology company that manufactures and distributes medical devices for the treatment of patients with chronic diseases at home. The Company's areas of therapeutic focus are vascular disease, oncology and providing airway clearance therapy for those suffering from chronic respiratory conditions. It is developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease. It markets Flexitouch Plus and Entre Plus systems as at-home therapies for the treatment of lymphedema and chronic venous insufficiency. It markets AffloVest as an at-home therapy intended to promote airway clearance. Its Flexitouch Plus system is a fully automated, programmable, advanced pneumatic compression device. It also offers Kylee, a free mobile application that helps patients learn about lymphedema.
企業コードTCMD
会社名Tactile Systems Technology Inc
上場日Jul 28, 2016
最高経営責任者「CEO」Dodd (Sheri L)
従業員数1037
証券種類Ordinary Share
決算期末Jul 28
本社所在地3701 Wayzata Blvd, Suite 300
都市MINNEAPOLIS
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号55416
電話番号18333822845
ウェブサイトhttps://www.tactilemedical.com/
企業コードTCMD
上場日Jul 28, 2016
最高経営責任者「CEO」Dodd (Sheri L)
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし